Latest Breaking News On - Jonathan finn - Page 2 : comparemela.com

Atossa Therapeutics (NASDAQ:ATOS) Releases Earnings Results

Atossa Therapeutics (NASDAQ:ATOS – Get Free Report) issued its earnings results on Monday. The company reported ($0.05) earnings per share for the quarter, topping the consensus estimate of ($0.07) by $0.02, Zacks reports. Atossa Therapeutics Price Performance Shares of ATOS opened at $1.61 on Thursday. Atossa Therapeutics has a 12-month low of $0.62 and a […]

Jonathan finnAtossa therapeutics company profileCantor fitzgeraldAtossa therapeutics incAtossa therapeuticsGet free reportDirector jonathan finnAtossa therapeutics daily

Atossa Therapeutics (NASDAQ:ATOS) Releases Earnings Results, Beats Estimates By $0 02 EPS

Atossa Therapeutics (NASDAQ:ATOS) Releases Earnings Results, Beats Estimates By $0 02 EPS
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

Jonathan finnAtossa therapeutics incCantor fitzgeraldSecurities exchange commissionAtossa therapeuticsGet free reportDirector jonathan finnExchange commissionAtossa therapeutics daily

Short Interest in Atossa Therapeutics, Inc (NASDAQ:ATOS) Rises By 17 0%

Short Interest in Atossa Therapeutics, Inc (NASDAQ:ATOS) Rises By 17 0%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Jonathan finnExchange commissionAtossa therapeutics incCantor fitzgeraldAtossa therapeutics company profileAtossa therapeuticsGet free reportDirector jonathan finnFree reportAtossa therapeutics daily

Atossa Therapeutics, Inc (NASDAQ:ATOS) Short Interest Update

Atossa Therapeutics, Inc. (NASDAQ:ATOS – Get Free Report) was the target of a large growth in short interest during the month of April. As of April 15th, there was short interest totalling 12,350,000 shares, a growth of 17.0% from the March 31st total of 10,560,000 shares. Based on an average daily trading volume, of 1,620,000 […]

Jonathan finnAtossa therapeutics incCantor fitzgeraldAtossa therapeutics company profileAtossa therapeuticsGet free reportDirector jonathan finnFree reportTherapeutics trading downAtossa therapeutics dailyNasdaq atos

Jonathan Finn Buys 25,000 Shares of Atossa Therapeutics, Inc (NASDAQ:ATOS) Stock

Atossa Therapeutics, Inc. (NASDAQ:ATOS – Get Free Report) Director Jonathan Finn acquired 25,000 shares of Atossa Therapeutics stock in a transaction dated Wednesday, April 10th. The shares were purchased at an average price of $1.77 per share, for a total transaction of $44,250.00. Following the completion of the transaction, the director now directly owns 25,000 […]

Jonathan finnSecurities exchange commissionAtossa therapeutics company profileAtossa therapeutics incNorthern trust corpConnor clark lunn investment management ltdCapital partnersTopco ltdCantor fitzgeraldAtossa therapeuticsGet free reportDirector jonathan finnExchange commissionTrust corpLunn investment managementAtossa therapeutics daily